A Study of Brenipatide in Adult Participants With Schizophrenia
Clinical trial NCT07410507 · RECRUITING
Trial details
- NCT number
- NCT07410507
- Sponsor
- Eli Lilly and Company
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-10
- Primary completion
- 2027-11-01
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.